These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37837423)

  • 1. Identification of phytochemicals as putative ligands for the targeted modulation of peroxisome proliferator-activated receptor α (PPARα) in animals.
    Hassan FU; Rehman MS; Javed M; Ahmad K; Fatima I; Safdar M; Ashraf N; Nadeem A
    J Biomol Struct Dyn; 2023 Oct; ():1-12. PubMed ID: 37837423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico and in vitro analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat.
    Mandal SK; Kumar BK; Sharma PK; Murugesan S; Deepa PR
    Comput Biol Med; 2022 Aug; 147():105796. PubMed ID: 35809408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational investigation of phytochemicals from
    Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
    J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
    Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
    [No Abstract]   [Full Text] [Related]  

  • 5. In silico analysis of polyphenols modulate bovine PPARγ to increase milk fat synthesis in dairy cattle via the MAPK signalling pathways.
    Safdar M; Hassan F; Khan MS; Hassan Khan A; Junejo Y; Ozaslan M; Arain MA; Behan AA
    J Anim Sci; 2024 Aug; ():. PubMed ID: 39210246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
    Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
    J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer.
    Ballav S; Lokhande KB; Yadav RS; Ghosh P; Swamy KV; Basu S
    Mol Divers; 2023 Dec; 27(6):2867-2885. PubMed ID: 36544031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual Screening of
    Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Dual Agonists for PPARα/γ Receptors using Pharmacophore Modeling, Docking Analysis and Molecule Dynamics Simulation.
    Ding TT; Liu YY; Zhang LM; Shi JR; Xu WR; Li SY; Cheng XC
    Comb Chem High Throughput Screen; 2022; 25(9):1450-1461. PubMed ID: 34182904
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Joshi T; Joshi T; Sharma P; Pundir H; Chandra S
    J Biomol Struct Dyn; 2021 Aug; 39(13):4816-4834. PubMed ID: 32568603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach.
    D'Aniello E; Fellous T; Iannotti FA; Gentile A; Allarà M; Balestrieri F; Gray R; Amodeo P; Vitale RM; Di Marzo V
    Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):586-597. PubMed ID: 30611848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of potential bio-molecules from
    Mathpal S; Sharma P; Joshi T; Joshi T; Pande V; Chandra S
    J Biomol Struct Dyn; 2022; 40(20):9885-9896. PubMed ID: 34151733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches.
    Mir SA; Muhammad A; Padhiary A; Ekka NJ; Baitharu I; Naik PK; Nayak B
    J Biomol Struct Dyn; 2023; 41(21):12063-12076. PubMed ID: 36695102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational investigation of
    Yousaf MA; Anwer SA; Basheera S; Sivanandan S
    J Biomol Struct Dyn; 2024; 42(4):1901-1923. PubMed ID: 37154824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.
    Swain SS; Singh SR; Sahoo A; Hussain T; Pati S
    J Biomol Struct Dyn; 2022 Sep; 40(14):6463-6476. PubMed ID: 33583350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening, pharmacokinetics & MD simulation study of active phytoconstituents of
    Deshpande N S; Dwivedi PSR; Revanasiddappa BC
    J Biomol Struct Dyn; 2023 Nov; ():1-17. PubMed ID: 37948295
    [No Abstract]   [Full Text] [Related]  

  • 20. Rational design of thiazolidine-4-one-gallic acid hybrid derivatives as selective partial PPARγ modulators: an in-silico approach for type 2 diabetes treatment.
    Aryan ; Babu B; Divakar S; Gowramma B; Jupudi S; Chand J; Malakar Kumar V
    J Biomol Struct Dyn; 2023 Nov; ():1-15. PubMed ID: 37997952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.